Sun Pharmaceutical Industries Ltd SUNPHARMA-IN:National Stock Exchange of India

*Data is delayed | INR
Last | 05/20/22 IST
915.65quote price arrow up+31.05 (+3.51%)
Volume
2,877,917
52 week range
652.70 - 967.05
Loading...
  • Open893.00
  • Day High917.70
  • Day Low889.05
  • Prev Close884.60
  • 52 Week High967.05
  • 52 Week High Date04/29/22
  • 52 Week Low652.70
  • 52 Week Low Date06/18/21

Key Stats

  • Market Cap27,335.8M
  • Shares Out2,399.33M
  • 10 Day Average Volume3.25M
  • Dividend9.00
  • Dividend Yield0.98%
  • Beta-
  • YTD % Change8.36

KEY STATS

  • Open893.00
  • Day High917.70
  • Day Low889.05
  • Prev Close884.60
  • 52 Week High967.05
  • 52 Week High Date04/29/22
  • 52 Week Low652.70
  • 52 Week Low Date06/18/21
  • Market Cap27,335.8M
  • Shares Out2,399.33M
  • 10 Day Average Volume3.25M
  • Dividend9.00
  • Dividend Yield0.98%
  • Beta-
  • YTD % Change8.36

RATIOS/PROFITABILITY

  • EPS (TTM)26.82
  • P/E (TTM)34.14
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date02/09/2022
  • Div Amount7.00
  • Split Date-
  • Split Factor-

Latest On Sun Pharmaceutical Industries Ltd

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Sun Pharmaceutical Industries Limited is a specialty generic pharmaceutical company. The Company is engaged in the business of manufacturing, developing and marketing a range of generic formulations. It produces a portfolio of generic and specialty medicines targeting a spectrum of chronic and acute treatments. The Company’s product portfolio includes generics, branded generics, specialty, over the counter (OTC)/consumer healthcare products, anti-retrovirals (ARVs), active...
Israel Makov
Non-Executive Chairman of the Board
C. S. Muralidharan
Chief Financial Officer
Jila Breeze
Executive Vice President, Global Head - Quality
Aalok Shanghvi
Executive Vice President, Head - Emerging Markets, Head - Global Generics, Research and Development, Business Development
Pradeep Sanghvi
Executive Vice President, Head - Research and Development, US
Address
Sun House, CTS No. 201 B/1,, Western Exp
Mumbai
400063
India